Genomic Profiling Identifies 3 NSCLC Subtypes Predictive of Adjuvant Therapy Outcomes

December 02, 2021 03:00pm

Next-generation sequencing uncovered 3 subtypes of epidermal growth factor receptor–mutant stage 2 and 3 non–small cell lung cancer (NSCLC) that predicted patient outcomes to adjuvant therapy.

Field of Potential Adalimumab Biosimilar Contenders Continues to Grow
What We’re Reading: Omicron Variant Detected in US; Supreme Court Signals Support for Abortion Restrictions; Federal Judge Blocks Vaccine Mandate
Dr Adriaan Voors Explains Potential Decongestive Benefits of Empagliflozin
Treatment Guidelines and Recommendations for C. Diff Infection